Name
Bio Research Eesti OÜ
Registry code
12811028
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
05.03.2015 (9)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
72111 - Research and experimental development on biotechnology
688 096 €
341 204 €
50%
-
2 179 813 €
0
Submitted
No tax arrears
16%
14%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: INNA SIKORSKAJA 04.03.1968 (56) | 100% - 2 556.00 EUR | Board member | Direct ownership | |
| Tanel Mällas 25.07.1977 (47) | - | - | - | Founder |
| 2019 03.11.2020 | 2020 30.06.2021 | 2021 28.04.2022 | 2022 16.06.2023 | 2023 06.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 12 000 € | 780 218 € | 1 544 609 € | 1 253 130 € | 688 096 € |
| Net profit (loss) for the period | 21 954 € | 442 828 € | 244 954 € | 1 122 088 € | 341 204 € |
| Profit Margin | 183% | 57% | 16% | 90% | 50% |
| Current Assets | 43 873 € | 491 518 € | 1 400 590 € | 2 068 469 € | 2 395 685 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 43 873 € | 491 518 € | 1 400 590 € | 2 068 469 € | 2 395 685 € |
| Current Liabilities | 15 134 € | 19 951 € | 684 069 € | 229 860 € | 215 872 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 28 739 € | 471 567 € | 716 521 € | 1 838 609 € | 2 179 813 € |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 2 012.76 € | 2 089.29 € | - |
| 2023 Q4 | - | 2 012.76 € | 2 089.29 € | - |
| 2023 Q3 | - | 2 012.76 € | 2 089.29 € | - |
| 2023 Q2 | - | 2 012.76 € | 2 089.29 € | - |
| 2023 Q1 | - | 2 012.76 € | 2 089.29 € | - |
| 2022 Q4 | - | 2 012.76 € | 2 089.29 € | - |
| 2022 Q3 | - | 2 012.76 € | 2 089.29 € | - |
| 2022 Q2 | - | 2 012.76 € | 2 089.29 € | - |
| 2022 Q1 | - | 2 013.51 € | 2 089.29 € | - |
| 2021 Q4 | - | 2 012.76 € | 2 089.29 € | - |
| 2021 Q3 | - | 2 012.76 € | 2 089.29 € | - |
| 2021 Q2 | - | 2 012.76 € | 2 089.29 € | - |
| 2021 Q1 | - | 2 012.76 € | 2 089.29 € | 1 |
| 2020 Q4 | - | 1 341.84 € | 1 392.86 € | 1 |
| 2020 Q3 | - | - | - | 1 |
